Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems

Neurosci Lett. 1987 Mar 9;74(3):343-7. doi: 10.1016/0304-3940(87)90321-1.

Abstract

The hyperactivity induced by injection of the dopamine (DA) agonist apomorphine into the nucleus accumbens of rats was dose dependently inhibited by intra-accumbal pretreatment with cholecystokinin (CCK-8) (ED50, 0.34 ng). Local treatment with the opioid antagonist naloxone antagonized this inhibitory action of CCK-8 (ED50, 18 ng), but did not change the blocking effect of haloperidol on the apomorphine-induced hyperactivity. These data show that endogenous opioids are concerned in certain interactions between CCK-8 and DA systems.

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Dopamine / physiology*
  • Endorphins / physiology*
  • Haloperidol / pharmacology
  • Male
  • Motor Activity / physiology*
  • Naloxone / pharmacology*
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / physiology*
  • Rats
  • Rats, Inbred Strains
  • Septal Nuclei / physiology*
  • Sincalide / pharmacology*

Substances

  • Endorphins
  • Naloxone
  • Haloperidol
  • Sincalide
  • Apomorphine
  • Dopamine